Newsfeeds - Spark Newswire

3 minute read

General

Pulmatrix Issues Letter to Stockholders

Today, 1:58 PM

Pulmatrix, Inc. (NASDAQ:PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology,

PULM

2 minute read

20 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 1:58 PM

Gainers

APM

2 minute read

18 Stocks Moving in Friday’s Pre-Market Session

By Lisa Levin

Today, 1:58 PM

Gainers Medalist Diversified REIT, Inc. (NASDAQ: MDRR) rose 34.3% to $1.37 in pre-market trading after the company reported a stock repurchase program of 500,000 shares.

BFRI

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 1:58 PM

AVTE

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 1:58 PM

Gainers

ASLN

1 minute read

Legal
News

Pulmatrix Granted U.S. Patent Titled ‘Monovalent metal cation dry powders for inhalation’

By Benzinga Newsdesk

Today, 1:58 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6272&f=G&l=50&d=PTXT&p=126&S1=20211116&OS=20211116&RS=20211116

PULM

1 minute read

Pulmatrix Q3 EPS $(0.15) Up From $(0.31) YoY, Sales $1.07M Down From $4.37M YoY

By Benzinga Newsdesk

Today, 1:58 PM

Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.15) per share. This is a 51.61 percent increase over losses of $(0.31) per share from the same period last year. The company reported $1.07 million in sales this

PULM